{"gene":"USP44","run_date":"2026-06-11T09:02:06","timeline":{"discoveries":[{"year":2010,"finding":"USP44 encodes a catalytically active deubiquitinating enzyme that can cleave ubiquitin from ubiquitinated substrates both in vitro and in vivo. USP44 itself undergoes K48- and K63-linked polyubiquitination. The protein contains a ZnF-UBP domain and conserved catalytic residues (Cys, His, Asn/Asp). Subcellular localization studies showed predominant nuclear expression.","method":"In vitro deubiquitinase assay, in vivo ubiquitination assay, in situ hybridization, RT-PCR, immunofluorescence/localization","journal":"Cell biology international","confidence":"Medium","confidence_rationale":"Tier 1-2 / Weak — in vitro biochemical assay and mutagenesis context established catalytic activity, single lab, single study","pmids":["20402667"],"is_preprint":false},{"year":2012,"finding":"USP44 is a key regulator of APC/C activation during the mitotic checkpoint. Overexpression of USP44 promotes association of Mad2 with Cdc20, reinforcing the mitotic checkpoint, and stabilizes cyclin B1 in G2. High USP44 causes chromosome segregation errors and aneuploidy in non-transformed cells.","method":"Overexpression in murine embryonic fibroblasts, co-immunoprecipitation (Mad2-Cdc20 interaction), chromosome analysis, cyclin B1 degradation assays","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP, functional overexpression with specific phenotypic readouts, single lab with multiple orthogonal methods","pmids":["21853124"],"is_preprint":false},{"year":2012,"finding":"USP44 negatively regulates H2B monoubiquitination (H2Bub1) on lysine 120, acting as a deubiquitinase that opposes RNF20-mediated H2B ubiquitylation. Downregulation of USP44 during embryonic stem cell differentiation contributes to the increase in H2Bub1 required for efficient differentiation, particularly for transcriptional induction of long genes.","method":"USP44 knockdown/overexpression in ESCs, H2Bub1 ChIP, gene expression analysis, RNF20/USP44 epistasis","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal genetic manipulation, ChIP, functional differentiation assays; independently consistent with other H2Bub1 studies in the corpus","pmids":["22681888"],"is_preprint":false},{"year":2012,"finding":"USP44 prevents chromosome segregation errors by regulating centrosome separation, positioning, and mitotic spindle geometry through direct binding to the centriole protein centrin. This function is independent of its role in the mitotic checkpoint. Usp44-knockout mice develop spontaneous tumors.","method":"Usp44 knockout mouse engineering, chromosome lagging assays, centrosome positioning analysis, direct binding assay with centrin, mitotic spindle geometry measurements","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — knockout mouse model, multiple orthogonal cellular assays, direct protein-protein interaction (centrin binding), tumor phenotype in vivo","pmids":["23187126"],"is_preprint":false},{"year":2013,"finding":"USP44 is recruited to RNF168-generated ubiquitylation products at DNA double-strand break (DSB) sites and promotes efficient deubiquitylation of histone H2A. USP44 overexpression powerfully inhibits RNF8/RNF168-mediated 53BP1 retention at DSBs by reducing RNF168 accrual. Unlike USP29, USP44's activity is specific to ubiquitylated H2A.","method":"DUB overexpression screen, immunofluorescence for 53BP1 and RNF168 foci at DSBs, H2A deubiquitylation assay, USP44 depletion experiments","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct recruitment to DSB sites shown by imaging, specific H2A deubiquitylation established in vitro and in vivo, multiple orthogonal approaches in one study","pmids":["23615962"],"is_preprint":false},{"year":2016,"finding":"USP44 is an integral subunit of the nuclear receptor co-repressor (N-CoR) complex. Within this complex, USP44 directly deubiquitinates histone H2B in vitro and in vivo. Ablation of USP44 impairs the repressive activity of N-CoR. ChIP confirmed that USP44 recruitment reduces H2Bub1 at N-CoR target loci. USP44 depletion also impairs invasiveness of triple-negative breast cancer cells and increases global H2Bub1.","method":"Mass spectrometry identification of N-CoR complex components, co-immunoprecipitation, in vitro H2B deubiquitylation assay, ChIP, USP44 knockdown with invasion assay","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — biochemical reconstitution of H2B deubiquitylation in vitro, complex identified by MS, ChIP for chromatin targeting, functional knockdown with defined phenotype","pmids":["27880911"],"is_preprint":false},{"year":2019,"finding":"USP44 interacts with EZH2 and prevents its ubiquitination and proteasomal degradation, thereby stabilizing EZH2 protein and maintaining its gene silencing (H3K27 methyltransferase) activity. USP44 knockdown reduces EZH2 protein levels and inhibits tumorigenic characteristics of prostate cancer cells; ectopic EZH2 rescues the knockdown phenotype.","method":"Co-immunoprecipitation, ubiquitination assay, USP44 knockdown/rescue with EZH2, in vitro and in vivo tumor assays","journal":"Molecules and cells","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP for interaction, ubiquitination assay, rescue experiment; single lab, multiple methods","pmids":["30622230"],"is_preprint":false},{"year":2019,"finding":"USP44 promotes deubiquitination of FBP1 (fructose-1,6-bisphosphatase), increasing FBP1 protein expression in pancreatic cancer cells, which suppresses aerobic glycolysis and inhibits tumor progression and gemcitabine resistance.","method":"Co-immunoprecipitation, ubiquitination assay, USP44 overexpression/knockdown with FBP1 protein level measurement, cell proliferation and drug resistance assays","journal":"American journal of cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP and ubiquitination assays establish substrate-enzyme relationship; single lab","pmids":["31497353"],"is_preprint":false},{"year":2020,"finding":"USP44 interacts with and stabilizes FOXP3 in induced regulatory T cells (iTregs) by removing K48-linked ubiquitin modifications, preventing proteasomal degradation of FOXP3. TGF-β induces USP44 expression during iTreg differentiation. USP44 cooperates with USP7 to stabilize FOXP3. Tregs lacking USP44 show reduced suppressive function in vitro and in vivo.","method":"Co-immunoprecipitation, ubiquitination assay, USP44 genetic knockout in Tregs, in vitro Treg suppression assays, in vivo inflammatory models","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP, ubiquitination assay, genetic KO with defined functional phenotype in vitro and in vivo, multiple orthogonal methods","pmids":["32644293"],"is_preprint":false},{"year":2020,"finding":"USP44 is recruited to MITA/STING following DNA virus infection and removes K48-linked polyubiquitin moieties from MITA at K236, preventing proteasome-mediated degradation of MITA and sustaining innate antiviral signaling (type I IFN and pro-inflammatory cytokine induction). USP44-deficient mice show accelerated HSV-1-induced MITA degradation, reduced interferon induction, and greater susceptibility to HSV-1.","method":"Co-immunoprecipitation, ubiquitination assay (K48 linkage-specific), USP44-deficient mouse model, viral titer measurement, cytokine induction assays","journal":"PLoS pathogens","confidence":"High","confidence_rationale":"Tier 2 / Strong — specific site of deubiquitination identified (K236), KO mouse model, multiple orthogonal methods, in vivo viral infection phenotype","pmids":["31968013"],"is_preprint":false},{"year":2020,"finding":"USP44 overexpression increases Axin1 protein (but not mRNA) levels by interacting with Axin1 and reducing its ubiquitination, thereby stabilizing Axin1 and inactivating the Wnt/β-catenin pathway. Axin1 knockdown abolishes the anti-proliferative and pro-apoptotic effects of USP44 in colorectal cancer cells.","method":"Co-immunoprecipitation, ubiquitination assay, Axin1 knockdown rescue experiment, Wnt/β-catenin pathway target protein western blot","journal":"Cell biology international","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP, ubiquitination assay, epistasis rescue; single lab with multiple orthogonal methods","pmids":["32285989"],"is_preprint":false},{"year":2021,"finding":"USP44 directly deubiquitinates DDB2 to prevent its premature proteasomal degradation, selectively facilitating repair of UV-induced cyclobutane pyrimidine dimers (CPDs) through nucleotide excision repair (NER). Cells lacking USP44 show impaired DDB2 accumulation on DNA lesions and defective XPC retention. Usp44-null mice are prone to DMBA- and UV-induced tumors.","method":"In vitro deubiquitylation assay, USP44 KO cell lines and mouse models, ChIP/live-cell imaging of DDB2/XPC at lesions, tumor induction experiments","journal":"Frontiers in cell and developmental biology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — direct deubiquitylation in vitro, KO cells and mice, multiple mechanistic readouts at different pathway steps","pmids":["33937266"],"is_preprint":false},{"year":2022,"finding":"USP44 recruits and stabilizes the E3 ubiquitin ligase TRIM25 by removing K48-linked polyubiquitin chains at Lys439 of TRIM25. Stabilized TRIM25 then promotes degradation of Ku80, inhibiting its recruitment to DSBs and suppressing NHEJ DNA repair, thereby enhancing radiosensitivity.","method":"Co-immunoprecipitation, ubiquitination assay (K48 linkage, specific site Lys439), TRIM25 knockout rescue experiments, Ku80 recruitment assays at DSBs, in vitro and in vivo radiosensitivity assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — specific ubiquitination site identified (Lys439), epistasis rescue (TRIM25 KO reverses effect), in vitro and in vivo validation, multiple orthogonal methods","pmids":["35079021"],"is_preprint":false},{"year":2022,"finding":"USP44 interacts with WDR5 and represses its K48-linked ubiquitination and proteasomal degradation, stabilizing WDR5 protein. This interaction promotes T-ALL cell proliferation and survival; WDR5 overexpression rescues apoptosis induced by USP44 knockdown.","method":"Co-immunoprecipitation, co-localization, ubiquitination assay, USP44 knockdown/overexpression, WDR5 rescue experiments, in vivo xenograft","journal":"International journal of medical sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP and co-localization for interaction, ubiquitination assay, epistasis rescue; single lab","pmids":["36483601"],"is_preprint":false},{"year":2023,"finding":"USP44 directly interacts with Itch (an E3 ligase in Hedgehog signaling) and promotes its deubiquitination and stabilization. Stabilized Itch promotes proteasomal degradation of Gli1, thereby inactivating Hedgehog signaling and suppressing PDL1 expression in hepatocellular carcinoma.","method":"Quantitative proteomics, co-immunoprecipitation, ubiquitination assay, USP44 knockdown/overexpression, Gli1 and PDL1 measurement, in vitro and in vivo tumor assays","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP, ubiquitination assay, proteomics-identified substrate, in vitro/vivo functional validation; single lab","pmids":["38097536"],"is_preprint":false},{"year":2023,"finding":"MAD2 sequesters USP44 in the nucleus of cholangiocarcinoma cells, impairing formation of the USP44/LIMA1 complex in the cytoplasm and enhancing K48-linked ubiquitination and degradation of LIMA1, thereby activating the IGF1R/PI3K/AKT pathway and promoting cancer progression.","method":"Co-immunoprecipitation, ubiquitination assay, subcellular fractionation, USP44/LIMA1 complex analysis, AKT pathway readout","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP for complex formation, ubiquitination assay, subcellular localization analysis; single lab","pmids":["37752233"],"is_preprint":false},{"year":2024,"finding":"USP44 directly interacts with p21 (CDKN1A) and eliminates its K48-linked polyubiquitin chain in a cell cycle-independent manner, stabilizing p21 protein. This stabilization suppresses the G1/S transition and inhibits thyroid cancer cell proliferation; rescue of p21 partially reverses the effects of USP44 depletion.","method":"Co-immunoprecipitation, ubiquitination assay (K48-specific), USP44 knockdown/rescue with p21, cell cycle analysis, in vitro and in vivo proliferation assays","journal":"International journal of biological sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP, K48-specific ubiquitination assay, rescue epistasis; single lab","pmids":["39430240"],"is_preprint":false},{"year":2024,"finding":"USP44 directly interacts with BRCA2 in neuroblastoma cells, as established by proximity biotinylation (BioID) proteomics and validated by immunoprecipitation. Cells lacking USP44 show increased chromosome breaks and radial chromosomes after mitomycin C treatment, indicating a role for USP44 in the Fanconi anemia DNA repair pathway.","method":"BioID proximity biotinylation mass spectrometry, immunoprecipitation validation, chromosome breakage analysis in USP44-null cells after MMC treatment","journal":"Biomedicines","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — proximity proteomics plus co-IP validation, KO cells with functional chromosome breakage phenotype; single lab","pmids":["39767807"],"is_preprint":false},{"year":2024,"finding":"USP44 interacts with HEXIM1 and enhances HEXIM1 protein stability. Silencing HEXIM1 enhances the malignant phenotype of OSCC cells and reverses the antitumor effects of USP44 overexpression, placing HEXIM1 downstream of USP44.","method":"Co-IP mass spectrometry, label-free quantitative LC-MS/MS proteomics, co-immunoprecipitation, USP44 overexpression/knockdown, HEXIM1 knockdown rescue","journal":"Biology direct","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP/MS identified interaction, epistasis rescue; single lab","pmids":["39722007"],"is_preprint":false},{"year":2024,"finding":"USP44 stabilizes ITGB4 via deubiquitination, and this prevents cisplatin resistance in gastric cancer cells by modulating ROS and the MAPK/NF-κB pathway. ITGB4 affects P-gp expression and antioxidant enzyme activity through MAPK/NF-κB signaling.","method":"Proteomic analysis, co-immunoprecipitation, ubiquitination assay, USP44 overexpression/knockdown, ROS measurement, MAPK/NF-κB pathway readouts","journal":"FASEB journal","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, proteomic identification plus co-IP; mechanistic pathway details inferred from indirect readouts","pmids":["40824171"],"is_preprint":false},{"year":2025,"finding":"USP44 recruits and stabilizes STUB1 (CHIP E3 ligase) by removing K48-linked polyubiquitin chains at Lys30 of STUB1. Stabilized STUB1 promotes K48-linked polyubiquitination of LRPPRC at Lys453 and its degradation, increasing mitochondrial ROS accumulation and cisplatin-induced apoptosis in neuroblastoma.","method":"Co-immunoprecipitation, ubiquitination assay (K48 linkage, site-specific at Lys30 and Lys453), USP44 overexpression/knockdown, LRPPRC rescue experiments, mROS measurement","journal":"Neuro-oncology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — specific ubiquitination sites identified, co-IP, epistasis with LRPPRC rescue; single lab with multiple orthogonal methods","pmids":["39215663"],"is_preprint":false},{"year":2025,"finding":"EGR1 transcriptionally induces USP44 expression in cigarette smoke-exposed lung epithelial cells. USP44 then deubiquitinates and stabilizes TRAF6, promoting NLRP3 inflammasome-mediated pyroptosis. Inhibition of either EGR1 or USP44 reduces CSE-induced pyroptosis and alleviates COPD-like pathology in mice.","method":"Transcriptome sequencing, co-immunoprecipitation, ubiquitination assay, EGR1/USP44 knockdown in cellular and animal COPD models, pyroptosis assays (PI staining, caspase-1/GSDMD western blot)","journal":"Journal of inflammation research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP and ubiquitination assay for TRAF6 stabilization, in vivo COPD model, transcriptional regulation by EGR1; single lab","pmids":["41333036"],"is_preprint":false},{"year":2025,"finding":"USP44 interacts with EZH2 in triple-negative breast cancer cells, preventing EZH2 ubiquitination and proteasomal degradation, thereby promoting chemotherapy resistance. The EZH2 inhibitor GSK126 reverses the chemoresistance induced by USP44 overexpression.","method":"Co-immunoprecipitation, ubiquitination assay, USP44 knockdown/overexpression, EZH2 inhibitor treatment, in vivo xenograft models","journal":"Cancer biology & therapy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP and ubiquitination assay; replicates finding from PMID:30622230 in a different cancer context; single lab","pmids":["40619273"],"is_preprint":false},{"year":2025,"finding":"USP44 interacts with SENP2 and stabilizes it through deubiquitination, thereby inhibiting esophageal squamous cell carcinoma invasion and metastasis. Knockdown of SENP2 reduces the inhibitory effect of USP44 on ESCC cell migration.","method":"Liquid chromatography-mass spectrometry, co-immunoprecipitation, cycloheximide chase assay, ubiquitination analysis, USP44 overexpression/knockdown in vitro and in vivo","journal":"Clinical epigenetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — LC-MS interaction, co-IP, CHX chase, ubiquitination assay; single lab","pmids":["41250203"],"is_preprint":false},{"year":2025,"finding":"USP44 stabilizes MAOB (monoamine oxidase B) via deubiquitination in lung adenocarcinoma cells. The USP44-MAOB axis inhibits cisplatin resistance and malignant phenotypes; MAOB knockdown reverses USP44-mediated effects on DDP sensitivity.","method":"Co-immunoprecipitation, cycloheximide (CHX) chase assay, ubiquitination assay, USP44 overexpression/knockdown, MAOB knockdown rescue","journal":"International journal of genomics","confidence":"Low","confidence_rationale":"Tier 3 / Weak — co-IP and CHX chase, single lab, 0 citations, limited methodological detail in abstract","pmids":["42183175"],"is_preprint":false},{"year":2025,"finding":"USP44 protein delivered via bone marrow mesenchymal stem cell-derived extracellular vesicles stabilizes RBM14 through deubiquitination, protecting epididymal cells from radiation-induced DNA damage, apoptosis, and oxidative stress. Silencing USP44 in donor MSCs abrogates these protective effects.","method":"USP44 deubiquitination assay, USP44 knockdown in MSCs/EVs, RBM14 protein stability assay, cell viability, apoptosis, and DNA damage assays in irradiated cells","journal":"Stem cell research & therapy","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, primarily in vitro, limited mechanistic detail in abstract, 0 citations","pmids":["41299552"],"is_preprint":false}],"current_model":"USP44 is a nuclear deubiquitinating enzyme (DUB) with established roles in multiple cellular processes: it removes K48-linked ubiquitin chains from histone H2B (as part of the N-CoR repressor complex) and from histone H2A at DNA double-strand breaks (opposing the RNF8/RNF168 pathway); it stabilizes diverse protein substrates including MITA/STING (innate immune signaling), FOXP3 (Treg function), EZH2 (epigenetic regulation), DDB2 (nucleotide excision repair), Axin1 (Wnt pathway suppression), TRIM25, STUB1, TRAF6, and p21 (cell cycle control) through site-specific K48 deubiquitination; and it regulates mitotic fidelity by controlling Mad2-Cdc20 association at the APC/C and by binding centrin to regulate centrosome positioning and spindle geometry, thereby preventing chromosome segregation errors and suppressing tumorigenesis."},"narrative":{"mechanistic_narrative":"USP44 is a nuclear, catalytically active deubiquitinating enzyme (DUB) containing a ZnF-UBP domain and a canonical Cys/His/Asn-Asp catalytic triad, with broad roles in chromatin regulation, mitotic fidelity, DNA repair, and protein-stability control [PMID:20402667]. On chromatin it removes monoubiquitin from histone H2B-K120 in opposition to RNF20, a function deployed both during embryonic stem cell differentiation and as an integral subunit of the N-CoR co-repressor complex to maintain transcriptional repression [PMID:22681888, PMID:27880911]; it also deubiquitinates histone H2A at DNA double-strand breaks, antagonizing the RNF8/RNF168 cascade and limiting 53BP1 retention [PMID:23615962]. USP44 safeguards genome stability through two genetically separable mitotic activities — reinforcing the spindle-assembly checkpoint by promoting Mad2–Cdc20 association at the APC/C, and controlling centrosome separation, positioning, and spindle geometry via direct binding to centrin — and its loss in mice produces spontaneous and carcinogen-induced tumors [PMID:21853124, PMID:23187126, PMID:33937266]. A second, dominant theme is site-specific removal of K48-linked polyubiquitin chains to stabilize diverse substrates, including the innate-immune adaptor MITA/STING at K236, FOXP3, the E3 ligases TRIM25 (K439) and STUB1 (K30), DDB2 in nucleotide excision repair, Axin1, TRAF6, and the CDK inhibitor p21 [PMID:31968013, PMID:32644293, PMID:35079021, PMID:39215663, PMID:33937266, PMID:32285989, PMID:41333036, PMID:39430240]. Through these substrates USP44 modulates antiviral interferon signaling, regulatory T-cell suppressive function, DNA-repair pathway choice, Wnt and Hedgehog signaling, and cell-cycle progression, and acts contextually as a tumor suppressor or, by stabilizing EZH2, as a driver of tumor phenotypes [PMID:31968013, PMID:32644293, PMID:30622230, PMID:32285989].","teleology":[{"year":2010,"claim":"Establishing that USP44 is a genuine enzyme was the prerequisite for all downstream mechanism: the founding study showed it cleaves ubiquitin from substrates and defined its catalytic architecture and nuclear localization.","evidence":"In vitro and in vivo deubiquitinase assays, domain/catalytic-residue analysis, and immunofluorescence localization","pmids":["20402667"],"confidence":"Medium","gaps":["No physiological substrate identified at this stage","Linkage specificity of cleavage not defined","Single-lab biochemical characterization"]},{"year":2012,"claim":"Two 2012 studies placed USP44 at the heart of mitotic fidelity, showing it reinforces the spindle checkpoint via Mad2-Cdc20 at the APC/C and, separately, controls centrosome and spindle geometry through centrin binding.","evidence":"Overexpression in MEFs with co-IP of Mad2-Cdc20 and cyclin B1 assays; Usp44-knockout mice with chromosome lagging, centrosome positioning, and direct centrin-binding assays","pmids":["21853124","23187126"],"confidence":"High","gaps":["Direct APC/C substrate of USP44's DUB activity in this context not defined","Mechanism by which centrin binding controls spindle geometry not resolved","Relationship between the checkpoint and centrosome functions left genetically separable but mechanistically distinct"]},{"year":2012,"claim":"USP44 was identified as a histone H2B deubiquitinase opposing RNF20, linking it to transcriptional control during differentiation.","evidence":"Reciprocal knockdown/overexpression in ESCs with H2Bub1 ChIP and gene-expression/epistasis analysis","pmids":["22681888"],"confidence":"High","gaps":["Genomic targeting determinants of USP44 not defined","Whether H2B activity requires partner complexes unaddressed at this point"]},{"year":2013,"claim":"USP44 was shown to act at DNA double-strand breaks, deubiquitinating H2A and antagonizing the RNF8/RNF168-53BP1 axis, extending its chromatin role into DNA-damage signaling.","evidence":"DUB overexpression screen, 53BP1/RNF168 foci imaging, and H2A-specific deubiquitylation assays","pmids":["23615962"],"confidence":"High","gaps":["Recruitment mechanism to DSB sites only partly defined","Physiological balance with RNF168 in unperturbed repair unclear"]},{"year":2016,"claim":"Defining USP44 as an integral N-CoR subunit explained how its H2B deubiquitinase activity is targeted to specific repressed loci and tied it to cancer cell invasiveness.","evidence":"Mass-spectrometric identification of the N-CoR complex, co-IP, in vitro H2B deubiquitylation, ChIP, and knockdown invasion assays","pmids":["27880911"],"confidence":"High","gaps":["Stoichiometry and assembly of USP44 within N-CoR not resolved","Direct vs complex-dependent contribution to invasion not separated"]},{"year":2019,"claim":"A series of substrate-stabilization studies began showing USP44 protects target proteins from proteasomal degradation, with EZH2 and FBP1 as early examples in cancer.","evidence":"Co-IP, ubiquitination assays, and knockdown/rescue with EZH2 or FBP1 in prostate and pancreatic cancer cells","pmids":["30622230","31497353"],"confidence":"Medium","gaps":["Ubiquitin-chain linkage and exact deubiquitination sites not always mapped","Direct vs indirect deubiquitination not fully distinguished"]},{"year":2020,"claim":"USP44 was established as a K48-specific stabilizer of immune and signaling regulators — MITA/STING (at K236), FOXP3, and Axin1 — connecting it to antiviral interferon signaling, Treg suppressive function, and Wnt pathway inactivation.","evidence":"Co-IP, K48-linkage-specific ubiquitination assays, site mapping, USP44-deficient/knockout mouse models, viral infection and Treg suppression phenotypes","pmids":["31968013","32644293","32285989"],"confidence":"High","gaps":["How USP44 selects among these substrates in different cell types unclear","Cooperation with USP7 on FOXP3 mechanistically undefined","Stimulus-dependent recruitment to MITA only partly resolved"]},{"year":2021,"claim":"USP44 was shown to stabilize DDB2 to license nucleotide excision repair of UV photolesions, with knockout mice prone to carcinogen- and UV-induced tumors, reinforcing its tumor-suppressor role.","evidence":"In vitro deubiquitylation, KO cells and mice, DDB2/XPC lesion-recruitment imaging, and tumor-induction experiments","pmids":["33937266"],"confidence":"High","gaps":["Selectivity for CPD repair vs other NER substeps not fully explained","Regulation of USP44 recruitment to UV lesions undefined"]},{"year":2022,"claim":"USP44 was found to stabilize E3 ligases themselves (TRIM25 at K439) and chromatin factors (WDR5), revealing it can shape downstream ubiquitination cascades and DNA-repair pathway choice indirectly.","evidence":"Co-IP, site-specific K48 ubiquitination assays, TRIM25/WDR5 knockout-rescue, Ku80 recruitment and radiosensitivity assays","pmids":["35079021","36483601"],"confidence":"High","gaps":["Whether USP44 acts on TRIM25 and WDR5 in the same cells/contexts unknown","Broader network of USP44-stabilized E3 ligases not mapped"]},{"year":2023,"claim":"Substrate scope expanded to Hedgehog signaling (via Itch/Gli1) and to a regulatory layer where MAD2 sequesters USP44 in the nucleus to control cytoplasmic LIMA1 stability, illustrating spatial control of USP44 activity.","evidence":"Quantitative proteomics, co-IP, ubiquitination assays, subcellular fractionation, and rescue experiments in HCC and cholangiocarcinoma","pmids":["38097536","37752233"],"confidence":"Medium","gaps":["Mechanism and physiological generality of MAD2-mediated nuclear sequestration unclear","Direct vs indirect action on Gli1 via Itch not fully isolated"]},{"year":2024,"claim":"Multiple 2024 studies broadened the stabilized-substrate repertoire (p21, BRCA2, HEXIM1, ITGB4) and added a Fanconi-anemia-pathway role, consolidating USP44 as a context-dependent regulator of cell cycle, DNA repair, and chemoresistance.","evidence":"Co-IP, K48-specific ubiquitination assays, BioID proximity proteomics, cell-cycle and chromosome-breakage analyses, and rescue experiments across thyroid, neuroblastoma, OSCC and gastric cancer models","pmids":["39430240","39767807","39722007","40824171"],"confidence":"Medium","gaps":["Many substrate interactions rest on single-lab co-IP/proteomics without reciprocal or structural validation","Direct deubiquitination vs interaction-only relationships not always separated","ITGB4 axis (idx 19) is Low-confidence with pathway inferred from indirect readouts"]},{"year":2025,"claim":"Recent work extended USP44 substrate stabilization to STUB1 (K30), TRAF6, SENP2, MAOB and RBM14, linking it to mitochondrial ROS, inflammasome-driven pyroptosis, metastasis, and radioprotection, and identified EGR1 as a transcriptional inducer of USP44.","evidence":"Co-IP, site-specific and CHX-chase ubiquitination assays, transcriptome/proteomic profiling, KO/knockdown rescue, and in vivo disease models (COPD, neuroblastoma, ESCC, lung adenocarcinoma)","pmids":["39215663","41333036","41250203","42183175","41299552"],"confidence":"Medium","gaps":["Several 2025 substrates (MAOB, RBM14) are Low-confidence single-lab findings","Upstream regulation of USP44 beyond EGR1 largely undefined","Tissue-specific determinants of pro- vs anti-tumor activity unresolved"]},{"year":null,"claim":"It remains unresolved how a single nuclear DUB selects among its very large and context-divergent substrate set and how its opposing tumor-suppressor and tumor-promoting outcomes are determined.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model explaining substrate/linkage selectivity","No unified framework for cell-type-specific substrate engagement","Mechanism switching between genome-protective and oncogenic (e.g. EZH2-stabilizing) roles undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,2,4,5,9,12,16,20]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[0,4,5]},{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[2,4,5]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[9,8,12,20,11]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,15]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[4,11]},{"term_id":"GO:0005815","term_label":"microtubule organizing center","supporting_discovery_ids":[3]}],"pathway":[{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[1,3,16]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[4,11,12,17]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[2,5]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[9,8,21]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[9,8,12,20]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[10,14,15]}],"complexes":["N-CoR co-repressor complex"],"partners":["CENTRIN","MITA/STING","FOXP3","EZH2","TRIM25","STUB1","AXIN1","DDB2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9H0E7","full_name":"Ubiquitin carboxyl-terminal hydrolase 44","aliases":["Deubiquitinating enzyme 44","Ubiquitin thioesterase 44","Ubiquitin-specific-processing protease 44"],"length_aa":712,"mass_kda":81.2,"function":"Deubiquitinase that plays a key regulatory role in the spindle assembly checkpoint or mitotic checkpoint by preventing premature anaphase onset. Acts by specifically mediating deubiquitination of CDC20, a negative regulator of the anaphase promoting complex/cyclosome (APC/C) (PubMed:17443180). Deubiquitination of CDC20 leads to stabilize the MAD2L1-CDC20-APC/C ternary complex (also named mitotic checkpoint complex), thereby preventing premature activation of the APC/C (PubMed:17443180). Promotes association of MAD2L1 with CDC20 and reinforces the spindle assembly checkpoint (PubMed:17443180). Also promotes the deubiquitination of histone H2A and H2B (PubMed:23615962, PubMed:27880911). Recruited to RNF8/RNF168-ubiquitinated chromatin surrounding double stranded breaks (DSBs), promotes hydrolysis of such ubiquitin conjugates, thus negatively regulating protein recruitment to damaged chromatin (PubMed:23615962). Participates in nucleotide excision repair (NER) pathway by deubiquitinating DDB2 to prevent its premature degradation so it can remain on damaged chromatin (By similarity). Promotes FOXP3 stabilization through 'Lys-48'-linked deubiquitination leading to increased stability and increased regulatory T-cell lineage stability (PubMed:32644293). Also plays a positive role in innate immune response to DNA viruses by deubiquitinating STING1, selectively removing its 'Lys-48'-linked polyubiquitin chains and stabilizing it (PubMed:31968013)","subcellular_location":"Nucleus; Cytoplasm","url":"https://www.uniprot.org/uniprotkb/Q9H0E7/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/USP44","classification":"Not Classified","n_dependent_lines":7,"n_total_lines":1208,"dependency_fraction":0.005794701986754967},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/USP44","total_profiled":1310},"omim":[{"mim_id":"610993","title":"UBIQUITIN-SPECIFIC PROTEASE 44; USP44","url":"https://www.omim.org/entry/610993"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoli fibrillar center","reliability":"Approved"},{"location":"Microtubules","reliability":"Approved"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"testis","ntpm":22.6}],"url":"https://www.proteinatlas.org/search/USP44"},"hgnc":{"alias_symbol":["FLJ14528"],"prev_symbol":[]},"alphafold":{"accession":"Q9H0E7","domains":[{"cath_id":"3.30.40.10","chopping":"1-106_143-181","consensus_level":"medium","plddt":78.5877,"start":1,"end":181}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9H0E7","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H0E7-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H0E7-F1-predicted_aligned_error_v6.png","plddt_mean":71.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=USP44","jax_strain_url":"https://www.jax.org/strain/search?query=USP44"},"sequence":{"accession":"Q9H0E7","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9H0E7.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9H0E7/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9H0E7"}},"corpus_meta":[{"pmid":"22681888","id":"PMC_22681888","title":"RNF20 and USP44 regulate stem cell differentiation by modulating H2B monoubiquitylation.","date":"2012","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/22681888","citation_count":177,"is_preprint":false},{"pmid":"23187126","id":"PMC_23187126","title":"USP44 regulates centrosome positioning to prevent aneuploidy and suppress tumorigenesis.","date":"2012","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/23187126","citation_count":148,"is_preprint":false},{"pmid":"23615962","id":"PMC_23615962","title":"The deubiquitylating enzyme USP44 counteracts the DNA double-strand break response mediated by the RNF8 and RNF168 ubiquitin ligases.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23615962","citation_count":117,"is_preprint":false},{"pmid":"35079021","id":"PMC_35079021","title":"USP44 regulates irradiation-induced DNA double-strand break repair and suppresses tumorigenesis in nasopharyngeal carcinoma.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35079021","citation_count":81,"is_preprint":false},{"pmid":"32644293","id":"PMC_32644293","title":"The deubiquitinase USP44 promotes Treg function during inflammation by preventing FOXP3 degradation.","date":"2020","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/32644293","citation_count":64,"is_preprint":false},{"pmid":"21853124","id":"PMC_21853124","title":"Overexpression of ubiquitin specific protease 44 (USP44) induces chromosomal instability and is frequently observed in human T-cell leukemia.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21853124","citation_count":59,"is_preprint":false},{"pmid":"26232424","id":"PMC_26232424","title":"USP44+ Cancer Stem Cell Subclones Contribute to Breast Cancer Aggressiveness by Promoting Vasculogenic Mimicry.","date":"2015","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/26232424","citation_count":53,"is_preprint":false},{"pmid":"32934196","id":"PMC_32934196","title":"Linc-RA1 inhibits autophagy and promotes radioresistance by preventing H2Bub1/USP44 combination in glioma cells.","date":"2020","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/32934196","citation_count":45,"is_preprint":false},{"pmid":"32285989","id":"PMC_32285989","title":"USP44 suppresses proliferation and enhances apoptosis in colorectal cancer cells by inactivating the Wnt/β-catenin pathway via Axin1 deubiquitination.","date":"2020","source":"Cell biology international","url":"https://pubmed.ncbi.nlm.nih.gov/32285989","citation_count":42,"is_preprint":false},{"pmid":"30622230","id":"PMC_30622230","title":"USP44 Promotes the Tumorigenesis of Prostate Cancer Cells through EZH2 Protein Stabilization.","date":"2019","source":"Molecules and cells","url":"https://pubmed.ncbi.nlm.nih.gov/30622230","citation_count":41,"is_preprint":false},{"pmid":"32445925","id":"PMC_32445925","title":"CircFOXO3 functions as a molecular sponge for miR-143-3p to promote the progression of gastric carcinoma via upregulating USP44.","date":"2020","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/32445925","citation_count":41,"is_preprint":false},{"pmid":"31497353","id":"PMC_31497353","title":"USP44 suppresses pancreatic cancer progression and overcomes gemcitabine resistance by deubiquitinating FBP1.","date":"2019","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/31497353","citation_count":40,"is_preprint":false},{"pmid":"27880911","id":"PMC_27880911","title":"USP44 Is an Integral Component of N-CoR that Contributes to Gene Repression by Deubiquitinating Histone H2B.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/27880911","citation_count":40,"is_preprint":false},{"pmid":"24837038","id":"PMC_24837038","title":"Epigenetic inactivation of the candidate tumor suppressor USP44 is a frequent and early event in colorectal neoplasia.","date":"2014","source":"Epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/24837038","citation_count":38,"is_preprint":false},{"pmid":"31968013","id":"PMC_31968013","title":"USP44 positively regulates innate immune response to DNA viruses through deubiquitinating MITA.","date":"2020","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/31968013","citation_count":30,"is_preprint":false},{"pmid":"35433957","id":"PMC_35433957","title":"Increased m6A modification of lncRNA DBH-AS1 suppresses pancreatic cancer growth and gemcitabine resistance via the miR-3163/USP44 axis.","date":"2022","source":"Annals of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35433957","citation_count":30,"is_preprint":false},{"pmid":"23187131","id":"PMC_23187131","title":"The deubiquitinase USP44 is a tumor suppressor that protects against chromosome missegregation.","date":"2012","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/23187131","citation_count":29,"is_preprint":false},{"pmid":"20402667","id":"PMC_20402667","title":"K48- and K63-linked polyubiquitination of deubiquitinating enzyme USP44.","date":"2010","source":"Cell biology international","url":"https://pubmed.ncbi.nlm.nih.gov/20402667","citation_count":23,"is_preprint":false},{"pmid":"34572834","id":"PMC_34572834","title":"USP44 Promoter Methylation in Plasma Cell-Free DNA in Prostate Cancer.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/34572834","citation_count":19,"is_preprint":false},{"pmid":"38097536","id":"PMC_38097536","title":"The deubiquitinating enzyme USP44 suppresses hepatocellular carcinoma progression by inhibiting Hedgehog signaling and PDL1 expression.","date":"2023","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/38097536","citation_count":15,"is_preprint":false},{"pmid":"37752233","id":"PMC_37752233","title":"MAD2 activates IGF1R/PI3K/AKT pathway and promotes cholangiocarcinoma progression by interfering USP44/LIMA1 complex.","date":"2023","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/37752233","citation_count":15,"is_preprint":false},{"pmid":"32956592","id":"PMC_32956592","title":"USP44 hypermethylation promotes cell proliferation and metastasis in breast cancer.","date":"2020","source":"Future oncology (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/32956592","citation_count":15,"is_preprint":false},{"pmid":"36380875","id":"PMC_36380875","title":"Insight into the physiological and pathological roles of USP44, a potential tumor target (Review).","date":"2022","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/36380875","citation_count":11,"is_preprint":false},{"pmid":"36483601","id":"PMC_36483601","title":"USP44 accelerates the growth of T-cell acute lymphoblastic leukemia through interacting with WDR5 and repressing its ubiquitination.","date":"2022","source":"International journal of medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36483601","citation_count":11,"is_preprint":false},{"pmid":"33937266","id":"PMC_33937266","title":"USP44 Stabilizes DDB2 to Facilitate Nucleotide Excision Repair and Prevent Tumors.","date":"2021","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/33937266","citation_count":11,"is_preprint":false},{"pmid":"39215663","id":"PMC_39215663","title":"The deubiquitinase USP44 enhances cisplatin chemosensitivity through stabilizing STUB1 to promote LRPPRC degradation in neuroblastoma.","date":"2025","source":"Neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/39215663","citation_count":10,"is_preprint":false},{"pmid":"36016503","id":"PMC_36016503","title":"Methylation-sensitive high-resolution melting analysis of the USP44 promoter can detect early-stage hepatocellular carcinoma in blood samples.","date":"2022","source":"BMB reports","url":"https://pubmed.ncbi.nlm.nih.gov/36016503","citation_count":10,"is_preprint":false},{"pmid":"30639577","id":"PMC_30639577","title":"USP44 is dispensable for normal hematopoietic stem cell function, lymphocyte development, and B-cell-mediated immune response in a mouse model.","date":"2019","source":"Experimental hematology","url":"https://pubmed.ncbi.nlm.nih.gov/30639577","citation_count":9,"is_preprint":false},{"pmid":"33647455","id":"PMC_33647455","title":"CRADD and USP44 mutations in intellectual disability, mild lissencephaly, brain atrophy, developmental delay, strabismus, behavioural problems and skeletal anomalies.","date":"2021","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33647455","citation_count":9,"is_preprint":false},{"pmid":"39430240","id":"PMC_39430240","title":"USP44 inactivation accelerates the progression of thyroid cancer by inducing ubiquitylation and degradation of p21.","date":"2024","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/39430240","citation_count":8,"is_preprint":false},{"pmid":"37791390","id":"PMC_37791390","title":"CBX7 reprograms metabolic flux to protect against meningioma progression by modulating the USP44/c-MYC/LDHA axis.","date":"2024","source":"Journal of molecular cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/37791390","citation_count":6,"is_preprint":false},{"pmid":"39722007","id":"PMC_39722007","title":"USP44 regulates HEXIM1 stability to inhibit tumorigenesis and metastasis of oral squamous cell carcinoma.","date":"2024","source":"Biology direct","url":"https://pubmed.ncbi.nlm.nih.gov/39722007","citation_count":3,"is_preprint":false},{"pmid":"41333036","id":"PMC_41333036","title":"Chronic Exposure to Cigarette Smoke Induces Pyroptosis in Pulmonary Epithelial Cells via EGR1/USP44/TRAF6 Axis in COPD.","date":"2025","source":"Journal of inflammation research","url":"https://pubmed.ncbi.nlm.nih.gov/41333036","citation_count":3,"is_preprint":false},{"pmid":"40619273","id":"PMC_40619273","title":"USP44 promotes chemotherapeutic drug resistance of triple negative breast cancer through EZH2 protein stability.","date":"2025","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/40619273","citation_count":2,"is_preprint":false},{"pmid":"38500512","id":"PMC_38500512","title":"Mechanism of miR-98-5p in gastric cancer cell proliferation, migration, and invasion through the USP44/CTCFL axis.","date":"2024","source":"Toxicology research","url":"https://pubmed.ncbi.nlm.nih.gov/38500512","citation_count":2,"is_preprint":false},{"pmid":"39767807","id":"PMC_39767807","title":"Proximity Proteomics Reveals USP44 Forms a Complex with BRCA2 in Neuroblastoma Cells and Is Required to Prevent Chromosome Breakage.","date":"2024","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/39767807","citation_count":1,"is_preprint":false},{"pmid":"41250203","id":"PMC_41250203","title":"Hypermethylated USP44 deubiquitinates SENP2: a critical mechanism in esophageal cancer progression and a new target for intervention.","date":"2025","source":"Clinical epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/41250203","citation_count":1,"is_preprint":false},{"pmid":"40922130","id":"PMC_40922130","title":"USP44, ZNF454, and GPRC5B ctDNA Methylation Markers in Breast Cancer: Limited Clinical Relevance for Disease Monitoring and Tumor Characteristics.","date":"2025","source":"Asia-Pacific journal of clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/40922130","citation_count":1,"is_preprint":false},{"pmid":"37816258","id":"PMC_37816258","title":"RNA-binding protein NOVA1 promotes acute T-lymphocyte leukemia progression by stabilizing USP44 mRNA.","date":"2023","source":"Biochemistry and cell biology = Biochimie et biologie cellulaire","url":"https://pubmed.ncbi.nlm.nih.gov/37816258","citation_count":0,"is_preprint":false},{"pmid":"40824171","id":"PMC_40824171","title":"USP44 Regulates Chemoresistance Induced by ROS and the MAPK/NF-κB Pathway Through the Stabilization of ITGB4 in Gastric Cancer.","date":"2025","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/40824171","citation_count":0,"is_preprint":false},{"pmid":"42080060","id":"PMC_42080060","title":"Clinical Relevance of USP44 Expression and DNA Methylation Status in Breast Cancer Cell Lines, Tumor Tissues, and Circulating Tumor DNA.","date":"2026","source":"Breast cancer (Dove Medical Press)","url":"https://pubmed.ncbi.nlm.nih.gov/42080060","citation_count":0,"is_preprint":false},{"pmid":"39659944","id":"PMC_39659944","title":"Effect of subcutaneous adipose tissue-associated CSRP2 on the progression of prostate cancer via the WDR5/USP44 pathway.","date":"2024","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/39659944","citation_count":0,"is_preprint":false},{"pmid":"42183175","id":"PMC_42183175","title":"USP44 Stabilizes MAOB via Deubiquitination to Inhibit Cisplatin Resistance in Lung Adenocarcinoma.","date":"2026","source":"International journal of genomics","url":"https://pubmed.ncbi.nlm.nih.gov/42183175","citation_count":0,"is_preprint":false},{"pmid":"41299552","id":"PMC_41299552","title":"Protective effects of mouse bone marrow mesenchymal stem cell-derived extracellular vesicles on radiation-induced epididymal cells damage via USP44/RBM14 axis.","date":"2025","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/41299552","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":22863,"output_tokens":6767,"usd":0.085047,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":15677,"output_tokens":5091,"usd":0.10283,"stage2_stop_reason":"end_turn"},"total_usd":0.187877,"stage1_batch_id":"msgbatch_01UT1AahFPCAyn2uVweS7A9z","stage2_batch_id":"msgbatch_01HuKWtKNT4Pqj1bc8eEP5RV","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2010,\n      \"finding\": \"USP44 encodes a catalytically active deubiquitinating enzyme that can cleave ubiquitin from ubiquitinated substrates both in vitro and in vivo. USP44 itself undergoes K48- and K63-linked polyubiquitination. The protein contains a ZnF-UBP domain and conserved catalytic residues (Cys, His, Asn/Asp). Subcellular localization studies showed predominant nuclear expression.\",\n      \"method\": \"In vitro deubiquitinase assay, in vivo ubiquitination assay, in situ hybridization, RT-PCR, immunofluorescence/localization\",\n      \"journal\": \"Cell biology international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 / Weak — in vitro biochemical assay and mutagenesis context established catalytic activity, single lab, single study\",\n      \"pmids\": [\"20402667\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"USP44 is a key regulator of APC/C activation during the mitotic checkpoint. Overexpression of USP44 promotes association of Mad2 with Cdc20, reinforcing the mitotic checkpoint, and stabilizes cyclin B1 in G2. High USP44 causes chromosome segregation errors and aneuploidy in non-transformed cells.\",\n      \"method\": \"Overexpression in murine embryonic fibroblasts, co-immunoprecipitation (Mad2-Cdc20 interaction), chromosome analysis, cyclin B1 degradation assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP, functional overexpression with specific phenotypic readouts, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"21853124\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"USP44 negatively regulates H2B monoubiquitination (H2Bub1) on lysine 120, acting as a deubiquitinase that opposes RNF20-mediated H2B ubiquitylation. Downregulation of USP44 during embryonic stem cell differentiation contributes to the increase in H2Bub1 required for efficient differentiation, particularly for transcriptional induction of long genes.\",\n      \"method\": \"USP44 knockdown/overexpression in ESCs, H2Bub1 ChIP, gene expression analysis, RNF20/USP44 epistasis\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal genetic manipulation, ChIP, functional differentiation assays; independently consistent with other H2Bub1 studies in the corpus\",\n      \"pmids\": [\"22681888\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"USP44 prevents chromosome segregation errors by regulating centrosome separation, positioning, and mitotic spindle geometry through direct binding to the centriole protein centrin. This function is independent of its role in the mitotic checkpoint. Usp44-knockout mice develop spontaneous tumors.\",\n      \"method\": \"Usp44 knockout mouse engineering, chromosome lagging assays, centrosome positioning analysis, direct binding assay with centrin, mitotic spindle geometry measurements\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — knockout mouse model, multiple orthogonal cellular assays, direct protein-protein interaction (centrin binding), tumor phenotype in vivo\",\n      \"pmids\": [\"23187126\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"USP44 is recruited to RNF168-generated ubiquitylation products at DNA double-strand break (DSB) sites and promotes efficient deubiquitylation of histone H2A. USP44 overexpression powerfully inhibits RNF8/RNF168-mediated 53BP1 retention at DSBs by reducing RNF168 accrual. Unlike USP29, USP44's activity is specific to ubiquitylated H2A.\",\n      \"method\": \"DUB overexpression screen, immunofluorescence for 53BP1 and RNF168 foci at DSBs, H2A deubiquitylation assay, USP44 depletion experiments\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct recruitment to DSB sites shown by imaging, specific H2A deubiquitylation established in vitro and in vivo, multiple orthogonal approaches in one study\",\n      \"pmids\": [\"23615962\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"USP44 is an integral subunit of the nuclear receptor co-repressor (N-CoR) complex. Within this complex, USP44 directly deubiquitinates histone H2B in vitro and in vivo. Ablation of USP44 impairs the repressive activity of N-CoR. ChIP confirmed that USP44 recruitment reduces H2Bub1 at N-CoR target loci. USP44 depletion also impairs invasiveness of triple-negative breast cancer cells and increases global H2Bub1.\",\n      \"method\": \"Mass spectrometry identification of N-CoR complex components, co-immunoprecipitation, in vitro H2B deubiquitylation assay, ChIP, USP44 knockdown with invasion assay\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — biochemical reconstitution of H2B deubiquitylation in vitro, complex identified by MS, ChIP for chromatin targeting, functional knockdown with defined phenotype\",\n      \"pmids\": [\"27880911\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"USP44 interacts with EZH2 and prevents its ubiquitination and proteasomal degradation, thereby stabilizing EZH2 protein and maintaining its gene silencing (H3K27 methyltransferase) activity. USP44 knockdown reduces EZH2 protein levels and inhibits tumorigenic characteristics of prostate cancer cells; ectopic EZH2 rescues the knockdown phenotype.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, USP44 knockdown/rescue with EZH2, in vitro and in vivo tumor assays\",\n      \"journal\": \"Molecules and cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP for interaction, ubiquitination assay, rescue experiment; single lab, multiple methods\",\n      \"pmids\": [\"30622230\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"USP44 promotes deubiquitination of FBP1 (fructose-1,6-bisphosphatase), increasing FBP1 protein expression in pancreatic cancer cells, which suppresses aerobic glycolysis and inhibits tumor progression and gemcitabine resistance.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, USP44 overexpression/knockdown with FBP1 protein level measurement, cell proliferation and drug resistance assays\",\n      \"journal\": \"American journal of cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP and ubiquitination assays establish substrate-enzyme relationship; single lab\",\n      \"pmids\": [\"31497353\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"USP44 interacts with and stabilizes FOXP3 in induced regulatory T cells (iTregs) by removing K48-linked ubiquitin modifications, preventing proteasomal degradation of FOXP3. TGF-β induces USP44 expression during iTreg differentiation. USP44 cooperates with USP7 to stabilize FOXP3. Tregs lacking USP44 show reduced suppressive function in vitro and in vivo.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, USP44 genetic knockout in Tregs, in vitro Treg suppression assays, in vivo inflammatory models\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP, ubiquitination assay, genetic KO with defined functional phenotype in vitro and in vivo, multiple orthogonal methods\",\n      \"pmids\": [\"32644293\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"USP44 is recruited to MITA/STING following DNA virus infection and removes K48-linked polyubiquitin moieties from MITA at K236, preventing proteasome-mediated degradation of MITA and sustaining innate antiviral signaling (type I IFN and pro-inflammatory cytokine induction). USP44-deficient mice show accelerated HSV-1-induced MITA degradation, reduced interferon induction, and greater susceptibility to HSV-1.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay (K48 linkage-specific), USP44-deficient mouse model, viral titer measurement, cytokine induction assays\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — specific site of deubiquitination identified (K236), KO mouse model, multiple orthogonal methods, in vivo viral infection phenotype\",\n      \"pmids\": [\"31968013\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"USP44 overexpression increases Axin1 protein (but not mRNA) levels by interacting with Axin1 and reducing its ubiquitination, thereby stabilizing Axin1 and inactivating the Wnt/β-catenin pathway. Axin1 knockdown abolishes the anti-proliferative and pro-apoptotic effects of USP44 in colorectal cancer cells.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, Axin1 knockdown rescue experiment, Wnt/β-catenin pathway target protein western blot\",\n      \"journal\": \"Cell biology international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP, ubiquitination assay, epistasis rescue; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"32285989\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"USP44 directly deubiquitinates DDB2 to prevent its premature proteasomal degradation, selectively facilitating repair of UV-induced cyclobutane pyrimidine dimers (CPDs) through nucleotide excision repair (NER). Cells lacking USP44 show impaired DDB2 accumulation on DNA lesions and defective XPC retention. Usp44-null mice are prone to DMBA- and UV-induced tumors.\",\n      \"method\": \"In vitro deubiquitylation assay, USP44 KO cell lines and mouse models, ChIP/live-cell imaging of DDB2/XPC at lesions, tumor induction experiments\",\n      \"journal\": \"Frontiers in cell and developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — direct deubiquitylation in vitro, KO cells and mice, multiple mechanistic readouts at different pathway steps\",\n      \"pmids\": [\"33937266\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"USP44 recruits and stabilizes the E3 ubiquitin ligase TRIM25 by removing K48-linked polyubiquitin chains at Lys439 of TRIM25. Stabilized TRIM25 then promotes degradation of Ku80, inhibiting its recruitment to DSBs and suppressing NHEJ DNA repair, thereby enhancing radiosensitivity.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay (K48 linkage, specific site Lys439), TRIM25 knockout rescue experiments, Ku80 recruitment assays at DSBs, in vitro and in vivo radiosensitivity assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — specific ubiquitination site identified (Lys439), epistasis rescue (TRIM25 KO reverses effect), in vitro and in vivo validation, multiple orthogonal methods\",\n      \"pmids\": [\"35079021\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"USP44 interacts with WDR5 and represses its K48-linked ubiquitination and proteasomal degradation, stabilizing WDR5 protein. This interaction promotes T-ALL cell proliferation and survival; WDR5 overexpression rescues apoptosis induced by USP44 knockdown.\",\n      \"method\": \"Co-immunoprecipitation, co-localization, ubiquitination assay, USP44 knockdown/overexpression, WDR5 rescue experiments, in vivo xenograft\",\n      \"journal\": \"International journal of medical sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP and co-localization for interaction, ubiquitination assay, epistasis rescue; single lab\",\n      \"pmids\": [\"36483601\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"USP44 directly interacts with Itch (an E3 ligase in Hedgehog signaling) and promotes its deubiquitination and stabilization. Stabilized Itch promotes proteasomal degradation of Gli1, thereby inactivating Hedgehog signaling and suppressing PDL1 expression in hepatocellular carcinoma.\",\n      \"method\": \"Quantitative proteomics, co-immunoprecipitation, ubiquitination assay, USP44 knockdown/overexpression, Gli1 and PDL1 measurement, in vitro and in vivo tumor assays\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP, ubiquitination assay, proteomics-identified substrate, in vitro/vivo functional validation; single lab\",\n      \"pmids\": [\"38097536\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"MAD2 sequesters USP44 in the nucleus of cholangiocarcinoma cells, impairing formation of the USP44/LIMA1 complex in the cytoplasm and enhancing K48-linked ubiquitination and degradation of LIMA1, thereby activating the IGF1R/PI3K/AKT pathway and promoting cancer progression.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, subcellular fractionation, USP44/LIMA1 complex analysis, AKT pathway readout\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP for complex formation, ubiquitination assay, subcellular localization analysis; single lab\",\n      \"pmids\": [\"37752233\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"USP44 directly interacts with p21 (CDKN1A) and eliminates its K48-linked polyubiquitin chain in a cell cycle-independent manner, stabilizing p21 protein. This stabilization suppresses the G1/S transition and inhibits thyroid cancer cell proliferation; rescue of p21 partially reverses the effects of USP44 depletion.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay (K48-specific), USP44 knockdown/rescue with p21, cell cycle analysis, in vitro and in vivo proliferation assays\",\n      \"journal\": \"International journal of biological sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP, K48-specific ubiquitination assay, rescue epistasis; single lab\",\n      \"pmids\": [\"39430240\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"USP44 directly interacts with BRCA2 in neuroblastoma cells, as established by proximity biotinylation (BioID) proteomics and validated by immunoprecipitation. Cells lacking USP44 show increased chromosome breaks and radial chromosomes after mitomycin C treatment, indicating a role for USP44 in the Fanconi anemia DNA repair pathway.\",\n      \"method\": \"BioID proximity biotinylation mass spectrometry, immunoprecipitation validation, chromosome breakage analysis in USP44-null cells after MMC treatment\",\n      \"journal\": \"Biomedicines\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — proximity proteomics plus co-IP validation, KO cells with functional chromosome breakage phenotype; single lab\",\n      \"pmids\": [\"39767807\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"USP44 interacts with HEXIM1 and enhances HEXIM1 protein stability. Silencing HEXIM1 enhances the malignant phenotype of OSCC cells and reverses the antitumor effects of USP44 overexpression, placing HEXIM1 downstream of USP44.\",\n      \"method\": \"Co-IP mass spectrometry, label-free quantitative LC-MS/MS proteomics, co-immunoprecipitation, USP44 overexpression/knockdown, HEXIM1 knockdown rescue\",\n      \"journal\": \"Biology direct\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP/MS identified interaction, epistasis rescue; single lab\",\n      \"pmids\": [\"39722007\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"USP44 stabilizes ITGB4 via deubiquitination, and this prevents cisplatin resistance in gastric cancer cells by modulating ROS and the MAPK/NF-κB pathway. ITGB4 affects P-gp expression and antioxidant enzyme activity through MAPK/NF-κB signaling.\",\n      \"method\": \"Proteomic analysis, co-immunoprecipitation, ubiquitination assay, USP44 overexpression/knockdown, ROS measurement, MAPK/NF-κB pathway readouts\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, proteomic identification plus co-IP; mechanistic pathway details inferred from indirect readouts\",\n      \"pmids\": [\"40824171\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"USP44 recruits and stabilizes STUB1 (CHIP E3 ligase) by removing K48-linked polyubiquitin chains at Lys30 of STUB1. Stabilized STUB1 promotes K48-linked polyubiquitination of LRPPRC at Lys453 and its degradation, increasing mitochondrial ROS accumulation and cisplatin-induced apoptosis in neuroblastoma.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay (K48 linkage, site-specific at Lys30 and Lys453), USP44 overexpression/knockdown, LRPPRC rescue experiments, mROS measurement\",\n      \"journal\": \"Neuro-oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — specific ubiquitination sites identified, co-IP, epistasis with LRPPRC rescue; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"39215663\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"EGR1 transcriptionally induces USP44 expression in cigarette smoke-exposed lung epithelial cells. USP44 then deubiquitinates and stabilizes TRAF6, promoting NLRP3 inflammasome-mediated pyroptosis. Inhibition of either EGR1 or USP44 reduces CSE-induced pyroptosis and alleviates COPD-like pathology in mice.\",\n      \"method\": \"Transcriptome sequencing, co-immunoprecipitation, ubiquitination assay, EGR1/USP44 knockdown in cellular and animal COPD models, pyroptosis assays (PI staining, caspase-1/GSDMD western blot)\",\n      \"journal\": \"Journal of inflammation research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP and ubiquitination assay for TRAF6 stabilization, in vivo COPD model, transcriptional regulation by EGR1; single lab\",\n      \"pmids\": [\"41333036\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"USP44 interacts with EZH2 in triple-negative breast cancer cells, preventing EZH2 ubiquitination and proteasomal degradation, thereby promoting chemotherapy resistance. The EZH2 inhibitor GSK126 reverses the chemoresistance induced by USP44 overexpression.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, USP44 knockdown/overexpression, EZH2 inhibitor treatment, in vivo xenograft models\",\n      \"journal\": \"Cancer biology & therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP and ubiquitination assay; replicates finding from PMID:30622230 in a different cancer context; single lab\",\n      \"pmids\": [\"40619273\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"USP44 interacts with SENP2 and stabilizes it through deubiquitination, thereby inhibiting esophageal squamous cell carcinoma invasion and metastasis. Knockdown of SENP2 reduces the inhibitory effect of USP44 on ESCC cell migration.\",\n      \"method\": \"Liquid chromatography-mass spectrometry, co-immunoprecipitation, cycloheximide chase assay, ubiquitination analysis, USP44 overexpression/knockdown in vitro and in vivo\",\n      \"journal\": \"Clinical epigenetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — LC-MS interaction, co-IP, CHX chase, ubiquitination assay; single lab\",\n      \"pmids\": [\"41250203\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"USP44 stabilizes MAOB (monoamine oxidase B) via deubiquitination in lung adenocarcinoma cells. The USP44-MAOB axis inhibits cisplatin resistance and malignant phenotypes; MAOB knockdown reverses USP44-mediated effects on DDP sensitivity.\",\n      \"method\": \"Co-immunoprecipitation, cycloheximide (CHX) chase assay, ubiquitination assay, USP44 overexpression/knockdown, MAOB knockdown rescue\",\n      \"journal\": \"International journal of genomics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — co-IP and CHX chase, single lab, 0 citations, limited methodological detail in abstract\",\n      \"pmids\": [\"42183175\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"USP44 protein delivered via bone marrow mesenchymal stem cell-derived extracellular vesicles stabilizes RBM14 through deubiquitination, protecting epididymal cells from radiation-induced DNA damage, apoptosis, and oxidative stress. Silencing USP44 in donor MSCs abrogates these protective effects.\",\n      \"method\": \"USP44 deubiquitination assay, USP44 knockdown in MSCs/EVs, RBM14 protein stability assay, cell viability, apoptosis, and DNA damage assays in irradiated cells\",\n      \"journal\": \"Stem cell research & therapy\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, primarily in vitro, limited mechanistic detail in abstract, 0 citations\",\n      \"pmids\": [\"41299552\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"USP44 is a nuclear deubiquitinating enzyme (DUB) with established roles in multiple cellular processes: it removes K48-linked ubiquitin chains from histone H2B (as part of the N-CoR repressor complex) and from histone H2A at DNA double-strand breaks (opposing the RNF8/RNF168 pathway); it stabilizes diverse protein substrates including MITA/STING (innate immune signaling), FOXP3 (Treg function), EZH2 (epigenetic regulation), DDB2 (nucleotide excision repair), Axin1 (Wnt pathway suppression), TRIM25, STUB1, TRAF6, and p21 (cell cycle control) through site-specific K48 deubiquitination; and it regulates mitotic fidelity by controlling Mad2-Cdc20 association at the APC/C and by binding centrin to regulate centrosome positioning and spindle geometry, thereby preventing chromosome segregation errors and suppressing tumorigenesis.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"USP44 is a nuclear, catalytically active deubiquitinating enzyme (DUB) containing a ZnF-UBP domain and a canonical Cys/His/Asn-Asp catalytic triad, with broad roles in chromatin regulation, mitotic fidelity, DNA repair, and protein-stability control [#0]. On chromatin it removes monoubiquitin from histone H2B-K120 in opposition to RNF20, a function deployed both during embryonic stem cell differentiation and as an integral subunit of the N-CoR co-repressor complex to maintain transcriptional repression [#2, #5]; it also deubiquitinates histone H2A at DNA double-strand breaks, antagonizing the RNF8/RNF168 cascade and limiting 53BP1 retention [#4]. USP44 safeguards genome stability through two genetically separable mitotic activities — reinforcing the spindle-assembly checkpoint by promoting Mad2–Cdc20 association at the APC/C, and controlling centrosome separation, positioning, and spindle geometry via direct binding to centrin — and its loss in mice produces spontaneous and carcinogen-induced tumors [#1, #3, #11]. A second, dominant theme is site-specific removal of K48-linked polyubiquitin chains to stabilize diverse substrates, including the innate-immune adaptor MITA/STING at K236, FOXP3, the E3 ligases TRIM25 (K439) and STUB1 (K30), DDB2 in nucleotide excision repair, Axin1, TRAF6, and the CDK inhibitor p21 [#9, #8, #12, #20, #11, #10, #21, #16]. Through these substrates USP44 modulates antiviral interferon signaling, regulatory T-cell suppressive function, DNA-repair pathway choice, Wnt and Hedgehog signaling, and cell-cycle progression, and acts contextually as a tumor suppressor or, by stabilizing EZH2, as a driver of tumor phenotypes [#9, #8, #6, #10].\"\n  ,\n  \"teleology\": [\n    {\n      \"year\": 2010,\n      \"claim\": \"Establishing that USP44 is a genuine enzyme was the prerequisite for all downstream mechanism: the founding study showed it cleaves ubiquitin from substrates and defined its catalytic architecture and nuclear localization.\",\n      \"evidence\": \"In vitro and in vivo deubiquitinase assays, domain/catalytic-residue analysis, and immunofluorescence localization\",\n      \"pmids\": [\"20402667\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"No physiological substrate identified at this stage\", \"Linkage specificity of cleavage not defined\", \"Single-lab biochemical characterization\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Two 2012 studies placed USP44 at the heart of mitotic fidelity, showing it reinforces the spindle checkpoint via Mad2-Cdc20 at the APC/C and, separately, controls centrosome and spindle geometry through centrin binding.\",\n      \"evidence\": \"Overexpression in MEFs with co-IP of Mad2-Cdc20 and cyclin B1 assays; Usp44-knockout mice with chromosome lagging, centrosome positioning, and direct centrin-binding assays\",\n      \"pmids\": [\"21853124\", \"23187126\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Direct APC/C substrate of USP44's DUB activity in this context not defined\", \"Mechanism by which centrin binding controls spindle geometry not resolved\", \"Relationship between the checkpoint and centrosome functions left genetically separable but mechanistically distinct\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"USP44 was identified as a histone H2B deubiquitinase opposing RNF20, linking it to transcriptional control during differentiation.\",\n      \"evidence\": \"Reciprocal knockdown/overexpression in ESCs with H2Bub1 ChIP and gene-expression/epistasis analysis\",\n      \"pmids\": [\"22681888\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Genomic targeting determinants of USP44 not defined\", \"Whether H2B activity requires partner complexes unaddressed at this point\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"USP44 was shown to act at DNA double-strand breaks, deubiquitinating H2A and antagonizing the RNF8/RNF168-53BP1 axis, extending its chromatin role into DNA-damage signaling.\",\n      \"evidence\": \"DUB overexpression screen, 53BP1/RNF168 foci imaging, and H2A-specific deubiquitylation assays\",\n      \"pmids\": [\"23615962\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Recruitment mechanism to DSB sites only partly defined\", \"Physiological balance with RNF168 in unperturbed repair unclear\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Defining USP44 as an integral N-CoR subunit explained how its H2B deubiquitinase activity is targeted to specific repressed loci and tied it to cancer cell invasiveness.\",\n      \"evidence\": \"Mass-spectrometric identification of the N-CoR complex, co-IP, in vitro H2B deubiquitylation, ChIP, and knockdown invasion assays\",\n      \"pmids\": [\"27880911\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Stoichiometry and assembly of USP44 within N-CoR not resolved\", \"Direct vs complex-dependent contribution to invasion not separated\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"A series of substrate-stabilization studies began showing USP44 protects target proteins from proteasomal degradation, with EZH2 and FBP1 as early examples in cancer.\",\n      \"evidence\": \"Co-IP, ubiquitination assays, and knockdown/rescue with EZH2 or FBP1 in prostate and pancreatic cancer cells\",\n      \"pmids\": [\"30622230\", \"31497353\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Ubiquitin-chain linkage and exact deubiquitination sites not always mapped\", \"Direct vs indirect deubiquitination not fully distinguished\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"USP44 was established as a K48-specific stabilizer of immune and signaling regulators — MITA/STING (at K236), FOXP3, and Axin1 — connecting it to antiviral interferon signaling, Treg suppressive function, and Wnt pathway inactivation.\",\n      \"evidence\": \"Co-IP, K48-linkage-specific ubiquitination assays, site mapping, USP44-deficient/knockout mouse models, viral infection and Treg suppression phenotypes\",\n      \"pmids\": [\"31968013\", \"32644293\", \"32285989\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"How USP44 selects among these substrates in different cell types unclear\", \"Cooperation with USP7 on FOXP3 mechanistically undefined\", \"Stimulus-dependent recruitment to MITA only partly resolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"USP44 was shown to stabilize DDB2 to license nucleotide excision repair of UV photolesions, with knockout mice prone to carcinogen- and UV-induced tumors, reinforcing its tumor-suppressor role.\",\n      \"evidence\": \"In vitro deubiquitylation, KO cells and mice, DDB2/XPC lesion-recruitment imaging, and tumor-induction experiments\",\n      \"pmids\": [\"33937266\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Selectivity for CPD repair vs other NER substeps not fully explained\", \"Regulation of USP44 recruitment to UV lesions undefined\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"USP44 was found to stabilize E3 ligases themselves (TRIM25 at K439) and chromatin factors (WDR5), revealing it can shape downstream ubiquitination cascades and DNA-repair pathway choice indirectly.\",\n      \"evidence\": \"Co-IP, site-specific K48 ubiquitination assays, TRIM25/WDR5 knockout-rescue, Ku80 recruitment and radiosensitivity assays\",\n      \"pmids\": [\"35079021\", \"36483601\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Whether USP44 acts on TRIM25 and WDR5 in the same cells/contexts unknown\", \"Broader network of USP44-stabilized E3 ligases not mapped\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Substrate scope expanded to Hedgehog signaling (via Itch/Gli1) and to a regulatory layer where MAD2 sequesters USP44 in the nucleus to control cytoplasmic LIMA1 stability, illustrating spatial control of USP44 activity.\",\n      \"evidence\": \"Quantitative proteomics, co-IP, ubiquitination assays, subcellular fractionation, and rescue experiments in HCC and cholangiocarcinoma\",\n      \"pmids\": [\"38097536\", \"37752233\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Mechanism and physiological generality of MAD2-mediated nuclear sequestration unclear\", \"Direct vs indirect action on Gli1 via Itch not fully isolated\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Multiple 2024 studies broadened the stabilized-substrate repertoire (p21, BRCA2, HEXIM1, ITGB4) and added a Fanconi-anemia-pathway role, consolidating USP44 as a context-dependent regulator of cell cycle, DNA repair, and chemoresistance.\",\n      \"evidence\": \"Co-IP, K48-specific ubiquitination assays, BioID proximity proteomics, cell-cycle and chromosome-breakage analyses, and rescue experiments across thyroid, neuroblastoma, OSCC and gastric cancer models\",\n      \"pmids\": [\"39430240\", \"39767807\", \"39722007\", \"40824171\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Many substrate interactions rest on single-lab co-IP/proteomics without reciprocal or structural validation\", \"Direct deubiquitination vs interaction-only relationships not always separated\", \"ITGB4 axis (idx 19) is Low-confidence with pathway inferred from indirect readouts\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Recent work extended USP44 substrate stabilization to STUB1 (K30), TRAF6, SENP2, MAOB and RBM14, linking it to mitochondrial ROS, inflammasome-driven pyroptosis, metastasis, and radioprotection, and identified EGR1 as a transcriptional inducer of USP44.\",\n      \"evidence\": \"Co-IP, site-specific and CHX-chase ubiquitination assays, transcriptome/proteomic profiling, KO/knockdown rescue, and in vivo disease models (COPD, neuroblastoma, ESCC, lung adenocarcinoma)\",\n      \"pmids\": [\"39215663\", \"41333036\", \"41250203\", \"42183175\", \"41299552\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Several 2025 substrates (MAOB, RBM14) are Low-confidence single-lab findings\", \"Upstream regulation of USP44 beyond EGR1 largely undefined\", \"Tissue-specific determinants of pro- vs anti-tumor activity unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved how a single nuclear DUB selects among its very large and context-divergent substrate set and how its opposing tumor-suppressor and tumor-promoting outcomes are determined.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"No structural model explaining substrate/linkage selectivity\", \"No unified framework for cell-type-specific substrate engagement\", \"Mechanism switching between genome-protective and oncogenic (e.g. EZH2-stabilizing) roles undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 2, 4, 5, 9, 12, 16, 20]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0, 4, 5]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [2, 4, 5]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [9, 8, 12, 20, 11]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 15]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [4, 11]},\n      {\"term_id\": \"GO:0005815\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [1, 3, 16]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [4, 11, 12, 17]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [2, 5]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [9, 8, 21]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [9, 8, 12, 20]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [10, 14, 15]}\n    ],\n    \"complexes\": [\n      \"N-CoR co-repressor complex\"\n    ],\n    \"partners\": [\n      \"centrin\",\n      \"MITA/STING\",\n      \"FOXP3\",\n      \"EZH2\",\n      \"TRIM25\",\n      \"STUB1\",\n      \"Axin1\",\n      \"DDB2\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}